BLIS Technologies Limited (BLT.NZ)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Scott Ogilvie Johnson B.Com., CMINSTD, M.B.A. | Chief Executive Officer | 383.22k | -- | -- |
| Mr. Richard Wingham B.Com., C.A. | Chief Financial Officer | -- | -- | -- |
| Dr. John David-Francis Hale BSc (Hons), Ph.D. | Chief Technology Officer | -- | -- | -- |
| Ms. Ashleigh Childs | People & Culture Manager | -- | -- | -- |
| Ms. Jennifer Walker B.A., M.B.A. | Chief Revenue Officer | -- | -- | -- |
| Ms. Melissa Drysdale B.A. | Head of Quality | -- | -- | -- |
BLIS Technologies Limited
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 38
Description
BLIS Technologies Limited, together with its subsidiaries, develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity. The company offers BLIS K12, an oral probiotic supplement to support ear, nose, and throat health, as well as for enhancing immunity and bad breath; BLIS M18, an oral probiotic to support teeth and gums health; and BLIS Q24, a probiotic supplement to balance the skin microbiome, restoring the health, clarity, and radiance. It also provides its products in the ENT, immune, dental, and skin areas. The company has operations in New Zealand, Asia Pacific, Europe Middle East and Africa, and North America. The company was incorporated in 2000 and is based in Dunedin, New Zealand.
Corporate Governance
Upcoming Events
May 22, 2025 at 10:59 AM UTC
BLIS Technologies Limited Earnings Date
Recent Events
Recent Events Information Not Available